Clinical trial
Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic…
NCT00250718 · New Mexico Cancer Research Alliance, Other · Terminated
Key facts
| NCT number | NCT00250718 |
|---|---|
| Title | Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach |
| Official title | Phase II Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-angiogenic Approach |
| Lead sponsor | New Mexico Cancer Research Alliance, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Cancer |
| Intervention type | Drug |
| Interventions | Vincristine, VP-16, Rituximab, Dexamethasone, Levofloxacin |
| Enrollment | 17 |
| Start date | Oct 1, 2004 |
| Primary completion | Nov 1, 2008 |
| Completion | May 1, 2014 |
| First posted | Nov 8, 2005 |
| Last update posted | Aug 3, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: